State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

Novo Nordisk gained approval for Wegovy in China in June, and will initially target Chinese patients willing to pay ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the reimbursement available from private employers and insurers, according to an ...

More people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows.

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Novo Nordisk has launched its blockbuster Wegovy weight-loss drug in China, adding the world’s second-largest economy to its ...

In an interview with The U.S. Sun, Social Security Advisors CEO Matthew Allen said it’s possible for retirees to get the ...

The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...